Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows. The research centers on how the nucleus of each human cell ...

Pritelivir, an investigational antiviral for herpes simplex virus, demonstrated strong efficacy in a phase 3 trial, with 62.7% of immunocompromised patients achieving lesion healing. The ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

According to a new study, the herpes simplex virus partially liquefies the densely packed, gel-like core of human cell nuclei ...